These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14669316)

  • 21. [Value of laboratory tests and echography in the diagnosis of biliary disease in the initial phase of acute pancreatitis].
    Parodi HC; Gutiérrez S; Lattanzi M; Martínez R; Colombato LO
    Acta Gastroenterol Latinoam; 1990; 20(3):137-44. PubMed ID: 2095097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A multi-center clinical study of N-acetylcysteine on chronic hepatitis B].
    Shi XF; Guo SH; Wu G; Mao Q; Yu YS; Wang JK; Zhang L; Wang ZY; Zhang XQ; Zhang QH; Zhao YR; Zeng WQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):20-3. PubMed ID: 15670485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Samsky MD; Dunning A; DeVore AD; Schulte PJ; Starling RC; Tang WH; Armstrong PW; Ezekowitz JA; Butler J; McMurray JJ; Teerlink JR; Voors AA; Metra M; Mentz RJ; O'Connor CM; Patel CB; Hernandez AF
    Eur J Heart Fail; 2016 Apr; 18(4):424-32. PubMed ID: 26707029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis in the aged.
    Gibiński K; Fojt E; Suchan L
    Digestion; 1973; 8(3):254-60. PubMed ID: 4146513
    [No Abstract]   [Full Text] [Related]  

  • 26. Attenuation of copaiba oil in hepatic damage in rats.
    Brito MV; Costa FD; Vasconcelos DM; Costa LA; Yasojima EY; Teixeira RK; Yamaki VN
    Acta Cir Bras; 2014 Dec; 29(12):776-80. PubMed ID: 25517489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of determining hyperfermentemia in acute viral hepatitis].
    Postovit VA; Gundalakh AI; Prokof'eva GA
    Klin Med (Mosk); 1982 Apr; 60(4):65-8. PubMed ID: 7098394
    [No Abstract]   [Full Text] [Related]  

  • 28. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning?
    McGovern AJ; Vitkovitsky IV; Jones DL; Mullins ME
    Clin Toxicol (Phila); 2015 Mar; 53(3):164-7. PubMed ID: 25652258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of N-acetyl cysteine (NAC), an organosulfur compound from Allium plants, on experimentally induced hepatic prefibrogenic events in Wistar rat.
    Nissar AU; Farrukh MR; Kaiser PJ; Rafiq RA; Afnan Q; Bhushan S; Adil HS; Subhash BC; Tasduq SA
    Phytomedicine; 2013 Jul; 20(10):828-33. PubMed ID: 23578993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appraisal of the mortality in acute fulminant viral hepatitis.
    Davis MA; Peters RL; Redeker AG; Reynolds TB
    N Engl J Med; 1968 Jun; 278(23):1248-53. PubMed ID: 5647755
    [No Abstract]   [Full Text] [Related]  

  • 32. Antioxidant Effect of Ukrain Versus N-Acetylcysteine Against Acute Biliary Pancreatitis in An Experimental Rat Model.
    Zeren S; Bayhan Z; Koçak C; Koçak FE; Metineren MH; Savran B; Kocak H; Algin MC; Kahraman C; Kocak A; Cosgun S
    J Invest Surg; 2017 Apr; 30(2):116-124. PubMed ID: 27690697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levamisole treatment in acute hepatitis.
    Ozsoylu S; Sargin C; Kocak N
    Clin Pediatr (Phila); 1981 Aug; 20(8):497-500. PubMed ID: 7018788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Level of total protein-bound hexoses in the blood serum and their excretion in the urine of patients with acute viral hepatitis (Botkin's disease)].
    Fedianin IuP; Rabinovich PD; Vaĭstukh SI
    Ter Arkh; 1974; 46(4):63-7. PubMed ID: 4428369
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum thymidine kinase activity in patients with acute viral hepatitis.
    Tanaka K; Sishido T; Morimoto M; Inoue S; Takamura Y; Masumura M
    Gastroenterol Jpn; 1993 Feb; 28(1):51-5. PubMed ID: 8440424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.
    Elsharkawy A; Eletreby R; Fouad R; Soliman Z; Abdallah M; Negm M; Mohey M; Esmat G
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):773-778. PubMed ID: 28480808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of N-acetyl-L-cysteine on liver damage induced by long-term CCl4 administration.
    Otrubová O; Turecký L; Uličná O; Janega P; Luha J; Muchová J
    Gen Physiol Biophys; 2018 Jan; 37(1):23-31. PubMed ID: 29424349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
    Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
    Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.